The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,260.00
Bid: 1,262.00
Ask: 1,266.00
Change: -26.00 (-2.02%)
Spread: 4.00 (0.317%)
Open: 1,296.00
High: 1,296.00
Low: 1,250.00
Prev. Close: 1,286.00
AVON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Restatement of FY22 Results

13 Oct 2023 07:00

RNS Number : 9980P
Avon Protection PLC
13 October 2023

13 October 2023

Avon Protection plc

("Avon Protection" or "the Group")

Full Year Trading Update and Restatement of Prior Year Financial Results to Reflect New Segmentation

"Full year performance in line with expectations, with a stronger H2 reflecting good strategic progress"

Avon Protection announces a trading update for the financial year ended 30 September 2023 ("FY 2023") ahead of the publication of its Year End Results on 21 November 2023.

Full year trading in line with the Board's expectations

As expected, trading in the second half of 2023 was stronger than in the first half, with order book growth and higher underlying earnings.

The order book as at 30 September 2023 showed growth of over 10% compared to the prior year, with strong demand for helmets offsetting expected softness in Respiratory demand. We now have $59m of outstanding orders for Next Generation Integrated Head Protection System ("NG IHPS") helmets and have recently received a further delivery order valued at over $7m for the Advanced Combat Helmet GEN II ("ACH GEN II"), bringing total outstanding orders for this helmet to over $20m.

As expected, revenue excluding armour in the second half was significantly above the first half, driven by the successful ramp up of the NG IHPS programme, encouraging sales of the new EPIC range of helmets and shipment of a previously announced large mask order.

H2 adjusted operating profit margin is broadly flat versus H1, with some early benefits from the strengthen and transform initiatives within our STAR strategy offsetting the mix effect of strong growth in the lower margin Head Protection business.

Net debt:EBITDA on a covenant basis at the end of FY 2023 is expected to have reduced to around 2.0 times, compared to 2.6 times at the end of H1 2023. This improvement is the result of our successful exit from the Armour business and the improved profitability in the second half of the year.

The year end net debt position on a covenant basis is now expected to be approximately $65m, as a result of the timing of cash receipts from the shipment of several large orders in the last month of the financial year. We expect the receivables associated with these orders to be paid during the first quarter of the 2024 financial year, which will further reduce net debt by up to $20m.

Good strategic and operational progress with our STAR strategy

The Group has continued to make good progress with the STAR strategy set out at the time of the Half Year Results. In particular, significant progress has been made in the detailed planning of the STAR strategic initiatives, which has confirmed that there is an excellent opportunity to grow the top line, improve margins and deliver strong cash generation and attractive returns on capital.

More broadly, there are several key proof points that have been achieved during the second half which speak to the Group's strategic progress and operational improvement.

· All outstanding armour products have now been delivered to our customers, and we therefore expect the Armour business to be classified as discontinued for FY 2023. This means that we now have a more profitable and focused business and a stronger platform for future growth.

· We have delivered over 10,000 NG IHPS helmets to the customer in line with our plan for H2 2023, with our initiatives to strengthen the Irvine and Salem plants resulting in significantly more reliable operational performance.

· We have received a further delivery order for the ACH GEN II helmet valued at over $7m, illustrating the DOD's confidence in our ability to deliver that programme.

· Following the launch of the EPIC helmet for the commercial market in H2 2023, we have received orders for over 5,500 helmets and have shipped 3,200 with good levels of productivity.

Jos Sclater, CEO of Avon Protection, commented:

"We are now seeing more reliable financial performance as a result of our actions to strengthen the business by increasing accountability and improving operations and programme management. In particular, we have demonstrated our ability to deliver helmets to the DOD, which is reflected by a stronger order book. Our focus is now turning to our multi-year plan to improve margins through the transform pillar of our STAR strategy. I am delighted to see the Avon team rising to the challenge of realising our full potential and remain excited by the significant opportunity to expand cash-backed margins, accelerate growth and improve return on capital."

Prior year comparators

At the Half Year Results, we announced a new operating model for the Group, with the creation of two Strategic Business Units (SBUs): Respiratory Protection and Head Protection. The implementation of this structure is now complete, with both SBUs fully resourced and internal performance management and reporting structures in place.

Our FY 2023 financial results will reflect the new organisational design, and prior year comparators are therefore provided below demonstrating FY 2022 financial results under the new segmental structure.

FY 2022 and H1 2023 Group and segmental performance

FY 2022

H1 2023

$m

Respiratory Protection

Head Protection

Adjusted total*

Respiratory Protection

Head Protection

Adjusted total*

Revenue

193.0

70.5

263.5

68.5

33.1

101.6

Adjusted EBITDA

42.4

(3.6)

38.8

17.5

(1.6)

15.9

Adjusted depreciation, amortisation and impairment

(8.9)

(6.5)

(15.4)

(3.9)

(3.1)

(7.0)

Adjusted operating profit/(loss)

33.5

(10.1)

23.4

13.6

(4.7)

8.9

*Adjusted total excluding Armour as previously disclosed in note 2.1, page 136 of the Group's 2022 Annual Report and Accounts.

For further enquiries, please contact:

Avon Protection plc

Jos Sclater, Chief Executive Officer

+44 1225 896 848

Rich Cashin, Chief Financial Officer

Rory Wiltshire, Investor Relations Manager

MHP

Tim Rowntree

+44 7817 458804

Ollie Hoare

avonprotection@mhpgroup.com

Legal Entity Identifier: 213800JM1AN62REBWA71

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

About Avon Protection:

Avon Protection make products that are trusted to protect the world's militaries and first responders.

Our dedicated teams achieve this by developing mission-critical solutions that enhance our customers' performance, efficiency and capability, whilst providing ever-increasing levels of protection.

With a portfolio that includes respiratory and head protection systems, we are renowned for our innovative thinking and our steadfast approach to manufacturing unrivalled products.

For further information, please visit our website www.avon-protection-plc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFFLESEEDSEDS
Date   Source Headline
20th Dec 201712:16 pmRNSHolding(s) in Company
18th Dec 201710:18 amRNSNotice of Annual Report and Accounts and AGM
6th Dec 20173:39 pmRNSDirector/PDMR Shareholding
6th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSUS Department of Defense Mask Systems Order
30th Nov 20174:20 pmRNSDirector/PDMR Shareholding
29th Nov 201711:10 amRNSDirector/PDMR Shareholding
24th Nov 20174:39 pmRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSFinal Results
8th Nov 20177:00 amRNSAward of US JE-RDAP CBRNe framework contract
7th Nov 201712:15 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:30 pmRNSPreferred bidder nomination
6th Oct 20173:42 pmRNSDirector/PDMR Shareholding
20th Sep 20175:01 pmRNSHolding(s) in Company
15th Sep 20177:00 amRNSPre-close trading update
12th Sep 20179:13 amRNSDirector/PDMR Shareholding
8th Sep 20179:07 amRNSDirector/PDMR Shareholding
4th Sep 201711:06 amRNSHolding(s) in Company
31st Aug 20174:08 pmRNSDirector/PDMR Shareholding
21st Aug 20172:06 pmRNSHolding(s) in Company
21st Aug 20171:53 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAppointment of Corporate Broker
14th Aug 20179:59 amRNSDirector/PDMR Shareholding
9th Aug 201710:16 amRNSDirector/PDMR Shareholding
8th Aug 20173:33 pmRNSDirector/PDMR Shareholding
8th Aug 20171:23 pmRNSHolding(s) in Company
31st Jul 201711:03 amRNSDirector/PDMR Shareholding
6th Jul 20171:18 pmRNSDirectors'/PDMR Shareholdings - SIP
6th Jun 201711:51 amRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSContract Award
16th May 20177:00 amRNSHalf-year Report
10th May 20177:00 amRNSDirectorate Change
8th May 201712:31 pmRNSDirector/PDMR Shareholding
6th Apr 20174:03 pmRNSDirector/PDMR Shareholding
7th Mar 201710:34 amRNSDirector/PDMR Shareholding
17th Feb 20175:45 pmRNSHolding(s) in Company
15th Feb 20172:34 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSDirectorate Change
8th Feb 20174:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20175:22 pmRNSHolding(s) in Company
2nd Feb 20175:13 pmRNSResult of AGM
2nd Feb 20177:00 amRNSTrading Update
26th Jan 20179:37 amRNSHolding(s) in Company
9th Jan 201710:20 amRNSDirector/PDMR Shareholding
3rd Jan 201710:14 amRNSHolding(s) in Company
20th Dec 20168:52 amRNSHolding(s) in Company
9th Dec 201610:43 amRNSDirector/PDMR Shareholding
9th Dec 201610:42 amRNSAnnual Report and Financial Statements 2015
7th Dec 20164:07 pmRNSDirector/PDMR Shareholding
5th Dec 20163:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.